HOME > Investors > Press Releases
2016-05-18
VM BioPharma Announces FDA Fast Track Designation Granted for Investigational Gene Therapy VM202 for Patients with Amyotrophic Lateral Sclerosis (ALS)
2016-04-25
Iranian, Korean firms ink MOU on traditional medicine
2016-03-23
2016.03(IR letter) Business Updates
2016-01-25
ViroMed reports operating profit increased by 342% from previous year
2016-01-22
ViroMed Publishes Results from Critical Limb Ischemia (CLI) Phase II Clinical Study
11 12 13 14 15 16 17 18 19 20